August 13, 2020         
Solis Health Plans Teams Up With The Miami Marlins For 2020 MLB Season   •   Kensington Teams Up with Microsoft to Create the Only Belt-Clip Case Solution Designed Exclusively for Surface Duo   •   Powerful and Proven: Community Health Workers Can Build Health and Equity During Pandemic & Beyond   •   Horror Movies and Romantic TV Series to Watch on Ultra Film this Summer   •   Grant Thornton names Weird Enough Productions as next Purple Paladin   •   Baron & Budd Shareholder Carla Burke Pickrel Named to Top 25 National Women Trial Lawyers   •   Corporate Social Responsibility Related News Releases and Story Ideas for Reporters, Bloggers and Media Outlets   •   Revolve Group Announces Second Quarter 2020 Financial Results   •   Phased-in Approach to Re-opening Schools a Solid Plan—CUPE BC   •   Housing Rights Advocates Take on Avalon Bay Communities in a Socially-Distant Protest   •   Phoenix Organizations Provide $112,500 in Technology for Catholic Elementary Schools   •   Kemper Donates $200,000 to UnidosUS COVID-19 Fund   •   COVID-19 Likely to Usher in “Decade of the Home,” According to Accenture Survey Research   •   Evening Bone Density Scan Appointments to Screen for Osteoporosis and Osteopenia Now Available at Women's Excellence of Southeas   •   Bye-Bye Bus, Hello Minivan: Cars Overtake School Buses as the Primary Mode of Back-to-School Transport, a Cars.com Survey Reveal   •   Latinas in Aviation Book Breaks Through Cultural Sound Barrier; Historic Work Details 22 Authors' Ascending Achievements, Contri   •   Facedrive Enters Into Strategic Partnership and Investment Agreement With Tally, Gamification Platform Founded by Super Bowl-win   •   PIQRAY® is approved and now available in Canada as the first and only treatment specifically for patients with a PIK3CA muta   •   BJG Electronics CEO Rick Flora Retires and Kent Smith is Named President & CEO   •   Pornhub Celebrates International Female Orgasm Day by Pausing Videos Most Viewed by Straight Men at 40% to Shed Light on Gender
Bookmark and Share

Cure SMA Urges Remaining States to Expedite Adoption of Newborn Screening for Spinal Muscular Atrophy

Cure SMA Urges Remaining States to Expedite Adoption of Newborn Screening for Spinal Muscular Atrophy

New Report Card Shows Two-Thirds of U.S. States Now Screen for SMA, Leaving 1 in 3 American Newborns Still at Risk for Delayed Diagnosis

PR Newswire

CHICAGO, July 7, 2020 /PRNewswire/ -- Cure SMA released a new report card highlighting that two-thirds of states have implemented screening for spinal muscular atrophy (SMA) as part of their newborn screening programs. The flipside of this tremendous progress, however, is that 1 in 3 newborns born in the U.S. are still at risk of a delayed SMA diagnosis, the most common genetic cause of mortality of kids under the age of 2 years.

"Our goal is to ensure all newborns in all U.S. states have the best chance at a healthy and full life, and the best way to do that is to implement nationwide screening for SMA at birth. We've made progress, but we need the rest of the country to catch up to better prepare families for the decisions that come with an SMA diagnosis," remarked Kenneth Hobby, President, Cure SMA.

SMA is a serious, life-threatening, neuromuscular disease affecting a person's ability to walk, swallow, and—in the most severe cases—even breathe. Thanks to important medical breakthroughs, there are now multiple effective SMA treatment options that can save babies' lives, delivering dramatically improved prognosis and quality of life. Early diagnosis and early treatment are essential for best outcomes of babies with SMA.

This month marks two years since the federal government added SMA to its Recommended Uniform Screening Panel (RUSP) list of conditions states should screen for as part of their state universal newborn screening programs. This is done by administering a simple genetic blood test.

A report card on the state of newborn screening for SMA breaks down all 50 states, and the District of Columbia, into two categories:

Screening States: 26 states have implemented permanent screening programs for SMA and have led the way in newborn screening, while 5 additional states currently screen newborns in their state through a pilot program or population study.

Non-Screening States: 3 states are taking the final steps toward implementation of permanent newborn screening for SMA, while 35 percent of states (16 total, plus the District of Columbia) still have critical actions that need to be taken toward adopting measures around screening their newborns for SMA.

"Early diagnosis leading to early treatment offers a family facing SMA the best possible outcome and that was our goal when we set out to get SMA added to the RUSP," said Jill Jarecki, Ph.D., Chief Scientific Officer, Cure SMA. "We now need states that have yet to implement newborn screening to act now so parents have the critical information they need to make the best decisions for their child and so that all families across the U.S. are treated equally."

Approximately one in every 11,000 live births in the U.S., and one in every 50 Americans is a genetic carrier of the SMA gene. To parents of a child with SMA, any delay in their ability to help their child is unacceptable, especially given the availability of effective treatments. Their baby's life is at risk, and without newborn screening, they may not know until it is too late.

About SMA

SMA is a progressive neurodegenerative disease that robs an individual of their ability to walk, swallow, and breathe. SMA is the leading genetic cause of death for infants. Symptoms can surface within the first 6 months of life (Type 1, the most severe and common), during the toddler years (Types 2 and 3), or in adulthood (Type 4, the least common form). SMA affects 1 in 11,000 births in the United States each year, and approximately 1 in 50 Americans is a genetic carrier. The good news is that there are now highly effective FDA-approved treatments for SMA that make it possible for individuals with SMA to achieve developmental milestones and live full and productive lives.

About Cure SMA

Cure SMA is dedicated to the treatment and cure of SMA. Since 1984, Cure SMA has grown to be the largest network of individuals, families, clinicians, and research scientists working together to advance SMA research, support affected individuals/caregivers, and educate public and professional communities about SMA. The organization has directed and invested in comprehensive research that has shaped the scientific community's understanding of SMA, led to breakthroughs in treatment and care, and provided individuals and families the support they need today. For more information, visit www.cureSMA.org.

Photo(s):

https://www.prlog.org/12828800

Press release distributed by PRLog

 

Cision View original content:http://www.prnewswire.com/news-releases/cure-sma-urges-remaining-states-to-expedite-adoption-of-newborn-screening-for-spinal-muscular-atrophy-301089311.html

SOURCE Cure SMA



Back to top
| Back to home page
Video

White House Live Stream
LIVE VIDEO EVERY SATURDAY
alsharpton Rev. Al Sharpton
9 to 11 am EST
jjackson Rev. Jesse Jackson
10 to noon CST


Video

LIVE BROADCASTS
Sounds Make the News ®
WAOK-Urban
Atlanta - WAOK-Urban
KPFA-Progressive
Berkley / San Francisco - KPFA-Progressive
WVON-Urban
Chicago - WVON-Urban
KJLH - Urban
Los Angeles - KJLH - Urban
WKDM-Mandarin Chinese
New York - WKDM-Mandarin Chinese
WADO-Spanish
New York - WADO-Spanish
WBAI - Progressive
New York - WBAI - Progressive
WOL-Urban
Washington - WOL-Urban

Listen to United Natiosns News